COR.NYSECencora, INC

Form 4: Cencora Executive Chairman Sells Shares

Sentiment:

Insider Transaction Report


Cencora's Executive Chairman, Steven H. Collis, exercised stock options and subsequently sold a portion of his common stock holdings.

Worse than expectedSteven H. Collis, Executive Chairman, sold 14,579 shares while exercising options for 12,579 shares, resulting in a net reduction of 2,000 shares in his direct beneficial ownership.While the sale was pre-planned under a Rule 10b5-1 plan, a net reduction in insider holdings can be perceived as a slightly negative signal regarding future prospects or valuation.

Summary

  • Steven H. Collis, Executive Chairman of Cencora, Inc. [COR], engaged in transactions on August 19, 2025.
  • Exercised non-qualified stock options to acquire 12,579 shares of common stock at an exercise price of $86.09 per share.
  • Sold 14,579 shares of common stock at a price of $289.98 per share.
  • The sale was conducted under a Rule 10b5-1 trading plan adopted on November 25, 2024.
  • Following these transactions, Steven H. Collis directly holds 307,912.665 shares of Cencora common stock.
  • Remaining non-qualified stock options beneficially owned are 88,049.

Sentiment

Score: 4

Explanation: The net sale of shares by a key executive, even under a 10b5-1 plan, is generally viewed as a slightly negative signal, indicating a reduction in insider alignment with shareholder interests. The exercise of options is positive, but the net disposition outweighs it in terms of sentiment.

Positives

  • Exercise of stock options indicates the realization of value from previously granted equity incentives.
  • The sale was conducted under a pre-arranged Rule 10b5-1 plan, suggesting it was not based on new, undisclosed negative information.

Negatives

  • Net reduction in direct beneficial ownership of common stock by a key executive (14,579 shares sold vs. 12,579 shares acquired through exercise).

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

  • Shareholders: A net reduction in insider ownership might be interpreted by some shareholders as a slight decrease in management's direct stake in the company's future performance, though the 10b5-1 plan mitigates this concern.

Key Dates

DateDescription
11/13/2020First annual installment date for option exercisability.
11/13/2021Second annual installment date for option exercisability.
11/13/2022Third annual installment date for option exercisability.
11/13/2023Fourth annual installment date for option exercisability.
11/25/2024Date Rule 10b5-1 plan was adopted by Steven H. Collis.
08/19/2025Date of stock option exercise and common stock sale transactions.
08/20/2025Date of filing of the Form 4.
11/13/2026Expiration date of the non-qualified stock option.

Recommendation

hold

While the net sale by a key executive is a slight negative signal, it was executed under a pre-arranged 10b5-1 plan, which reduces the implication of new negative information. The overall impact on the company's fundamentals is minimal, and the transaction primarily reflects personal financial planning rather than a change in company outlook. Therefore, a 'hold' recommendation is appropriate, advising investors to maintain their current positions while monitoring future developments.

Keywords

Cencora, COR, Steven H. Collis, insider trading, Form 4, stock options, Rule 10b5-1 plan, executive compensation, share sale

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.